Development and Scale-Up of a Manufacturing Route for the Non-nucleoside Reverse Transcriptase Inhibitor GSK2248761A (IDX-899): Synthesis of an Advanced Key Chiral Intermediate

Scale Up ◽

Transcriptase Inhibitor ◽

Faculty Opinions recommendation of Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12019956.13157054 ◽

2011 ◽

Author(s):

Mark Wainberg ◽

Dimitrios Coutsinos

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Subtype C ◽

Low Level ◽

Acute Hiv ◽

Reverse Transcriptase Inhibitor ◽

Hiv 1

A Nanoparticle-Encapsulated Non-Nucleoside Reverse-Transcriptase Inhibitor with Enhanced Anti-HIV-1 Activity and Prolonged Circulation Time in Plasma

Current Pharmaceutical Design ◽

10.2174/1381612820666141014125213 ◽

2014 ◽

Vol 21 (7) ◽

pp. 925-935 ◽

Cited By ~ 11

Author(s):

Wen Li ◽

Qian Wang ◽

Yuan Li ◽

Fei Yu ◽

Qi Liu ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Circulation Time ◽

Reverse Transcriptase Inhibitor ◽

Anti Hiv ◽

Hiv 1

Erratum to: Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis [J Hepatol (2019); 70 (5): 930–940]

Journal of Hepatology ◽

10.1016/j.jhep.2021.01.003 ◽

2021 ◽

Author(s):

Taesik Gwag ◽

Zhaojie Meng ◽

Yipeng Sui ◽

Robert N. Helsley ◽

Se-Hyung Park ◽

...

Keyword(s):

Reverse Transcriptase ◽

Hepatic Steatosis ◽

Transcriptase Inhibitor ◽

Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients

AIDS ◽

10.1097/00002030-200112070-00006 ◽

2001 ◽

Vol 15 (18) ◽

pp. 2385-2395 ◽

Cited By ~ 46

Author(s):

Andrew N. Phillips ◽

Christian Pradier ◽

Adriano Lazzarin ◽

Bonaventura Clotet ◽

Frank-Detlef Goebel ◽

...

Keyword(s):

Viral Load ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

A novel potent non-nucleoside reverse transcriptase inhibitor acylthiocarbamate derivative with extensive intramolecular π–π interactions

Acta Crystallographica Section C Crystal Structure Communications ◽

10.1107/s0108270106013175 ◽

2006 ◽

Vol 62 (6) ◽

pp. o315-o317 ◽

Cited By ~ 1

Author(s):

Angelo Mugnoli ◽

Alberto Borassi ◽

Andrea Spallarossa ◽

Sara Cesarini

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Π Interactions ◽

Apricitabine: A Nucleoside Reverse Transcriptase Inhibitor for HIV Infection

Annals of Pharmacotherapy ◽

10.1345/aph.1m160 ◽

2009 ◽

Vol 43 (10) ◽

pp. 1676-1683 ◽

Cited By ~ 2

Author(s):

Monica M Gaffney ◽

Paul P Belliveau ◽

Linda M Spooner

Keyword(s):

Hiv Infection ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

ChemInform Abstract: Efavirenz: A Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), and a Previous Structurally Related Development Candidate

ChemInform ◽

10.1002/chin.201151237 ◽

2011 ◽

Vol 42 (51) ◽

pp. no-no

Author(s):

Nobuyoshi Yasuda ◽

Lushi Tan

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Related Development ◽

Synthesis of a non-nucleoside reverse transcriptase inhibitor in the alkenyldiarylmethane (ADAM) series with optimized potency and therapeutic index

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/s0960-894x(97)10214-1 ◽

1998 ◽

Vol 8 (2) ◽

pp. 195-198 ◽

Cited By ~ 14

Author(s):

Mark Cushman ◽

Agustin Casimiro-Garcia ◽

Karen Williamson ◽

William G. Rice

Keyword(s):

Reverse Transcriptase ◽

Therapeutic Index ◽

Transcriptase Inhibitor ◽

Nucleoside Reverse-Transcriptase Inhibitor Dosing Errors in an Outpatient HIV Clinic in the Electronic Medical Record Era

Clinical Infectious Diseases ◽

10.1086/520653 ◽

2007 ◽

Vol 45 (5) ◽

pp. 658-661 ◽

Cited By ~ 15

Author(s):

J. H. Willig ◽

A. O. Westfall ◽

J. Allison ◽

N. V. Wagoner ◽

P.-W. Chang ◽

...

Keyword(s):

Reverse Transcriptase ◽

Medical Record ◽

Electronic Medical Record ◽

Transcriptase Inhibitor ◽

Immune Reconstitution Is Comparable in Antiretroviral‐Naive Subjects after 1 Year of Successful Therapy with a Nucleoside Reverse‐Transcriptase Inhibitor– or Protease Inhibitor–Containing Antiretroviral Regimen

The Journal of Infectious Diseases ◽

10.1086/379041 ◽

2003 ◽

Vol 188 (10) ◽

pp. 1444-1454 ◽

Cited By ~ 24

Author(s):

Alan L. Landay ◽

John Spritzler ◽

Harold Kessler ◽

Donna Mildvan ◽

Minya Pu ◽

...

Keyword(s):

Protease Inhibitor ◽

Reverse Transcriptase ◽

Immune Reconstitution ◽

Transcriptase Inhibitor ◽

Successful Therapy ◽